Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study.
about
[A randomized clinical trial on the clinical efficacy and toxicities of single-agent paclitaxel liposome versus paclitaxel liposome plus oxaliplatin as first-line chemotherapy for advanced non-small cell lung cancer in elderly patients].Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumorsERCC1, RRM1 and TUBB3 mRNA expression on the tumor response and overall survival of non-small cell lung cancer treated with platinum-based chemotherapyOxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer.XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studiesA randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer.Treatment of stage IIIb/IV non-small cell lung cancer with Pemetrexed plus Oxaliplatin after failure of Erlotinib as second-line treatmentInhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells.ERCC1 and BRCA1 mRNA expressions are associated with clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy.Genetic polymorphisms in XPG could predict clinical outcome of platinum-based chemotherapy for advanced non-small cell lung cancer.
P2860
Q33399713-0A21B8D4-26F4-4F62-ABFD-2EA80F1F1160Q34725699-8FD49F00-216A-4844-A631-AAF67A69811CQ35061055-F58CA54A-FC15-410A-85EB-5BAE516CBF3FQ35858069-B8BD8C60-CCEB-4E30-9945-CB40A5BA88C6Q36386267-3F5017B8-7C39-42D5-BCA7-582AA1DB6FDAQ36594055-F8AEEA18-EF47-4D20-8096-6FA86D1FBA17Q36886148-66956E9D-EBEC-40BF-B21F-3915CEEC6C55Q43196142-55CE09BB-4A25-4B7C-B61F-EB85CD0400CAQ44876602-A1498934-0317-4FC2-BC72-FA557431FD4AQ54218866-FB85A0E1-B885-4FC4-9DFF-C56C84D945E9
P2860
Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Randomized phase II three-arm ...... als in Medical Oncology study.
@ast
Randomized phase II three-arm ...... als in Medical Oncology study.
@en
type
label
Randomized phase II three-arm ...... als in Medical Oncology study.
@ast
Randomized phase II three-arm ...... als in Medical Oncology study.
@en
prefLabel
Randomized phase II three-arm ...... als in Medical Oncology study.
@ast
Randomized phase II three-arm ...... als in Medical Oncology study.
@en
P2093
P356
P1433
P1476
Randomized phase II three-arm ...... als in Medical Oncology study.
@en
P2093
B Formisano
D Cortinovis
P304
P356
10.1093/ANNONC/MDL415
P577
2006-11-16T00:00:00Z